News

Stories

See all

Updates: Lilly's Global COVID-19 Response

View Story

Lilly Creates Mobile Research Units to Reach Elderly Patients

View Story

How Next Generation VBAs Can Put Patients Front and Center

View Story

Indiana eLearning Lab and College Football Team Up

View Story

Lilly Insulin Value Program Savings Card Now Available Online

View Story

Realizing the Full Potential of Diagnostic Testing in Cancer Care

View Story


Press Releases

See all

Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)

August 3, 2020

Tags |  Product

- More than 40 percent of coronavirus deaths in the U.S. linked to long-term care facilities; urgent need for therapeutic strategies to prevent COVID-19 in this vulnerable population   - First-of-its-kind study will enroll up to 2,400 residents and staff at long-term care facilities; will utilize




Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance

July 30, 2020

Tags |  Financial

- Revenue in the second quarter of 2020 declined 2 percent, comprised of volume growth of 6 percent, a 7 percent decrease in realized prices and a 1 percent unfavorable impact from foreign exchange rates.   - The estimated negative impact of the COVID-19 pandemic on Q2 2020 revenue included




Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes

July 30, 2020

Tags |  Product

- Jardiance (empagliflozin) significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction   - Treatment of heart failure is an




Lilly's P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimer's Disease in Data Published in JAMA

July 28, 2020

Tags |  Product

New Alzheimer's disease blood test could enable early diagnosis and advance understanding of how disease impacts those living with it INDIANAPOLIS , July 28, 2020 /PRNewswire/ -- A new study on Lilly 's blood test for Alzheimer's disease (AD), P-tau217 (phosphorylated tau at threonine-217), was